Paclitaxel promotes liver graft survival in rats and inhibits hepatocellular carcinoma growth in vitro and is a potentially useful drug for transplant patients with liver cancer.
Iesalnieks
I
I
Department of Surgery, University of Regensburg, Regensburg, Germany.
Tange
S
S
Scherer
M N
MN
Graeb
C
C
Frank
E
E
Jauch
K W
KW
Geissler
E K
EK
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000517:prevention & control*; D002460:Cell Line; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008113:Liver Neoplasms / Q000517:prevention & control*; D016031:Liver Transplantation / Q000502:physiology*; D017239:Paclitaxel / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D051381:Rats; D011912:Rats, Inbred ACI; D011915:Rats, Inbred BUF; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous / Q000502:physiology
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel